Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Dottikon Es Holding AG    DESN   CH0020739006

DOTTIKON ES HOLDING AG

(DESN)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
1360(c) 1410(c) 1530(c) 1450(c) 1680(c) Last
201 543 687 519 2 019 Volume
+0.74% +3.68% +8.51% -5.23% +15.86% Change
More quotes
Financials
Sales 2019 148 M 163 M 163 M
Net income 2019 16,3 M 18,0 M 18,0 M
Net cash position 2019 43,8 M 48,4 M 48,4 M
P/E ratio 2019 34,2x
Yield 2019 -
Sales 2020 175 M 193 M 193 M
Net income 2020 33,2 M 36,6 M 36,6 M
Net cash position 2020 42,8 M 47,3 M 47,3 M
P/E ratio 2020 24,3x
Yield 2020 -
Capitalization 2 102 M 2 324 M 2 322 M
EV / Sales 2019 3,47x
EV / Sales 2020 4,36x
Nbr of Employees 630
Free-Float 21,1%
More Financials
Company
Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others,... 
More about the company
All news about DOTTIKON ES HOLDING AG
11/27DOTTIKON ES : Shareholders Approve all Proposals of the Board of Directors
PU
11/26HALF-YEAR REPORT 2020/21 : Growth, Higher Profitability and Construction of New ..
PU
11/24DOTTIKON ES HOLDING AG : half-yearly earnings release
07/03DOTTIKON ES : Shareholders Approve all Proposals of the Board of Directors
PU
05/29DOTTIKON ES : Condensed Annual Report 2019/20
PU
05/29DOTTIKON ES : Higher Sales and Net Income – Investments in Further Growth
PU
05/26DOTTIKON ES HOLDING AG : annual earnings release
2019DOTTIKON ES : Markus Blocher Reorganizes Equity Interest Structure, Increases To..
PU
2019HALF-YEAR REPORT 2019/20 : Strong Growth and Significant Net Income Increase
PU
2019DOTTIKON ES : Condensed Half-Year Report 2019/20
PU
2019DOTTIKON ES : Handover of Processes & Technologies Senior Management Position
PU
2019DOTTIKON ES : Shareholders Approve all Proposals of the Board of Directors
PU
2019ANNUAL REPORT 2018/19 : Stronger Second Half-Year, Full Business Year Below Prev..
PU
2019DOTTIKON ES : Condensed Annual Report 2018/19
PU
2018DOTTIKON ES : Lower Sales and Net Income
PU
More news
News in other languages on DOTTIKON ES HOLDING AG
11/27Dottikon-Aktionäre stimmen Kapitalerhöhung und Aktiensplit zu
11/27Bourse Zurich: juste dans le vert pour la dernière séance de la semaine
11/27DOTTIKON ES : Aktionäre stimmen allen Anträgen des Verwaltungsrates zu
11/27Bourse Zurich: le SMI à l'équilibre avant le weekend
11/27Dottikon ES améliore sa performance semestrielle, mise gros sur la pharma
More news
Chart DOTTIKON ES HOLDING AG
Duration : Period :
Dottikon Es Holding AG Technical Analysis Chart | DESN | CH0020739006 | MarketScreener
Technical analysis trends DOTTIKON ES HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers
NameTitle
Markus Blocher Chairman, Chief Executive Officer & MD
Marlene Born Chief Financial Officer
Urs Brändli Head-Processes & Technologies
Alfred Scheidegger Non-Executive Director
Stephan Kirschbaum Head-Business Development
Sector and Competitors
1st jan.Capitalization (M$)
DOTTIKON ES HOLDING AG182.83%2 324
INDIVIOR155.77%975
KNIGHT THERAPEUTICS INC.-27.18%554
MAYNE PHARMA GROUP LIMITED-17.24%441
CORMEDIX INC.23.08%288
ISOFOL MEDICAL AB (PUBL)-18.32%170